AN2 Therapeutics (ANTX) Other financing activities (2021 - 2026)
AN2 Therapeutics' (ANTX) quarterly Other financing activities came in at $39000.0 in Q1 2026, up 2.63% year-on-year from $38000.0 in Q1 2025, and up 454.55% on a QoQ basis from -$11000.0 in Q2 2025.
AN2 Therapeutics (ANTX) Other financing activities (2021 - 2026) Analysis & Trends
AN2 Therapeutics (ANTX) has 5 years of Other financing activities data on file, last reported at $39000.0 in Q1 2026.
- On a quarterly basis, Other financing activities rose 2.63% year-over-year to $39000.0 in Q1 2026; TTM through Mar 2026 was $28000.0, a 26.32% decrease from a year earlier, with the FY2025 full-year figure at $27000.0, down 88.0% from the prior year.
- Other financing activities for Q1 2026 stood at $39000.0, up from -$11000.0 in the prior quarter.
- Over the last five years, Other financing activities for ANTX reached as high as $63.2 million in Q1 2022 and fell as low as -$11000.0 in Q2 2025.
- Historically, Other financing activities has averaged $10.1 million across 4 years, with a median of $39000.0 in 2026.
- Across the five-year window, Other financing activities jumped 631880.0% in 2022 and sank 83.11% in 2025, its largest moves.
- Year by year, Other financing activities stood at -$10000.0 in 2022, then surged by 2350.0% to $225000.0 in 2024, then plunged by 104.89% to -$11000.0 in 2025, then soared by 454.55% to $39000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $39000.0 in Q1 2026, -$11000.0 in Q2 2025, and $38000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AN2 Therapeutics | 167.57 Mn | 167.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,000.00 |
| Mar 31, 2026 | 39,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Sep 30, 2022 | -10,000.00 |
| Sep 30, 2022 | -10,000.00 |
| Jun 30, 2022 | 7.18 Mn |
| Jun 30, 2022 | 7.18 Mn |
| Mar 31, 2022 | 63.20 Mn |
| Mar 31, 2022 | 63.20 Mn |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Mar 31, 2021 | 10,000.00 |